High Tide Inc. entered the German medical cannabis market by acquiring a majority stake in Remexian Pharma GmbH, which is based near Berlin.
7 reports, 5 independent
Updated Aug 25
Gone quiet
Reached 3 outlets in its first 24 hours
- Reports
- 7
- Developments
- 4
- Repetition
- 71%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
High Tide Inc. entered the German medical cannabis market by acquiring a majority stake in Remexian Pharma GmbH, which is based near Berlin.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.High Tide is scaling its German medical cannabis operations via Remexian, while also operating in Calgary.1 source
- Cronos provided High Tide Inc. with $30M in convertible debt financing on August 2, 2025.Sub-event
- High Tide Inc. is progressing a transaction with a German medical cannabis importer and appointing new executives.Sub-event
High Tide expands into Europe via acquisition of Remexian in the German medical cannabis sector.1 source
Keep exploring
The entities involved
-
Europe
terrestrial continent located in north-western Eurasia
Coverage
Newest first; wire copies grouped- leaderpost.com
- prnewswire.com
- Market ExclusiveWeekly Roundup on the Cannabis Sector & Psychedelic Sector Key Takeaways; Cannabis Sector High Tide Entered German Medical Cannabis Market with €27.2M Acquisition of Remexian Pharma Aurora Expanded G
- PR NewswireHigh Tide Announces Preliminary Q3 2025 Guidance The Company Expects Record Revenue, Adjusted EBITDA Ahead of Analyst Forecasts and a Two-Year High in Same-Store Sales Growth The Company Also Shares
- CNW GroupHigh Tide to Become Major Player in German Medical Cannabis Market Through Acquisition of Majority Stake in Remexian Pharma GmbH Remexian Generated €65 Million in Revenue in the Last 12 Months Remexi